HuGE Literature Finder
Records
1
-
5
Association of genetic variation of the six gene prognostic model for castration-resistant prostate cancer with survival. The Prostate 2018 Aug . Xie Wanling, Stopsack Konrad H, Drouin Sarah J, Fu Henry, Pomerantz Mark M, Mucci Lorelei A, Lee Gwo-Shu M, Kantoff Philip |
Prognostic impact of kinase-activating fusions and IKZF1 deletions in pediatric high-risk B-lineage acute lymphoblastic leukemia. Blood advances 2018 Mar 2 (5): 529-533. Tran Thai Hoa, Harris Marian H, Nguyen Jonathan V, Blonquist Traci M, Stevenson Kristen E, Stonerock Eileen, Asselin Barbara L, Athale Uma H, Clavell Luis A, Cole Peter D, Kelly Kara M, Laverdiere Caroline, Leclerc Jean-Marie, Michon Bruno, Schorin Marshall A, Welch Jennifer J G, Reshmi Shalini C, Neuberg Donna S, Sallan Stephen E, Loh Mignon L, Silverman Lewis |
KRAS driven expression signature has prognostic power superior to mutation status in non-small cell lung cancer. International journal of cancer 2016 Nov . Nagy Ádám, Pongor L?rinc Sándor, Szabó András, Santarpia Mariacarmela, Gy?rffy Balá |
Copy number variability analysis of pharmacogenes in patients with lymphoma, leukemia, hepatocellular, and lung carcinoma using The Cancer Genome Atlas data. Pharmacogenetics and genomics 2015 Jan 25 (1): 1-7. Kim In-Wha, Han Nayoung, Kim Myeong Gyu, Kim Therasa, Oh Jung |
A whole-blood RNA transcript-based prognostic model in men with castration-resistant prostate cancer: a prospective study. The Lancet. Oncology 2012 Nov 13 (11): 1105-13. Ross Robert W, Galsky Matthew D, Scher Howard I, Magidson Jay, Wassmann Karl, Lee Gwo-Shu Mary, Katz Leah, Subudhi Sumit K, Anand Aseem, Fleisher Martin, Kantoff Philip W, Oh William |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 28, 2022
- Content source: